Lipocine Announces Positive Week 52 Results from LPCN 1148 Phase 2 Study in Patients with Cirrhosis
Met primary and Hepatic Encephalopathy endpoints in Phase 2 studyIncrease in Skeletal Muscle Index observed at Week 24 was maintained through 52 weeksParticipants on placebo increased SMI when...